Advances in the management of idiopathic pulmonary fibrosis

Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elu...

Descripción completa

Detalles Bibliográficos
Autores principales: Ryu, Jay H, Daniels, Craig E
Formato: Texto
Lenguaje:English
Publicado: Medicine Reports 2010
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860576/
https://www.ncbi.nlm.nih.gov/pubmed/20436921
http://dx.doi.org/10.3410/M2-28
_version_ 1782180596012810240
author Ryu, Jay H
Daniels, Craig E
author_facet Ryu, Jay H
Daniels, Craig E
author_sort Ryu, Jay H
collection PubMed
description Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive.
format Text
id pubmed-2860576
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medicine Reports
record_format MEDLINE/PubMed
spelling pubmed-28605762010-10-14 Advances in the management of idiopathic pulmonary fibrosis Ryu, Jay H Daniels, Craig E F1000 Med Rep Review Article Idiopathic pulmonary fibrosis (IPF) is a common form of interstitial lung disease and usually results in progressive respiratory insufficiency and death. Steady progress has been made in understanding the pathogenesis of IPF and multiple clinical trials are ongoing, but effective therapy remains elusive. Medicine Reports 2010-04-12 /pmc/articles/PMC2860576/ /pubmed/20436921 http://dx.doi.org/10.3410/M2-28 Text en © 2010 Medicine Reports Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Ryu, Jay H
Daniels, Craig E
Advances in the management of idiopathic pulmonary fibrosis
title Advances in the management of idiopathic pulmonary fibrosis
title_full Advances in the management of idiopathic pulmonary fibrosis
title_fullStr Advances in the management of idiopathic pulmonary fibrosis
title_full_unstemmed Advances in the management of idiopathic pulmonary fibrosis
title_short Advances in the management of idiopathic pulmonary fibrosis
title_sort advances in the management of idiopathic pulmonary fibrosis
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2860576/
https://www.ncbi.nlm.nih.gov/pubmed/20436921
http://dx.doi.org/10.3410/M2-28
work_keys_str_mv AT ryujayh advancesinthemanagementofidiopathicpulmonaryfibrosis
AT danielscraige advancesinthemanagementofidiopathicpulmonaryfibrosis

Ejemplares similares